Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines
M McGillion, HM Arthur, A Cook, SL Carroll… - Canadian Journal of …, 2012 - Elsevier
Refractory angina (RFA) is a debilitating disease characterized by cardiac pain resistant to
conventional treatments for coronary artery disease including nitrates, calcium-channel and …
conventional treatments for coronary artery disease including nitrates, calcium-channel and …
[PDF][PDF] The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
A Di Monaco, A Sestito - European Review for Medical & …, 2012 - europeanreview.org
Ischemic heart disease (IHD) is a major cause of death in Western Countries and accounts
for very high costs worldwide. In this review we discussed the pathogenesis, symptoms …
for very high costs worldwide. In this review we discussed the pathogenesis, symptoms …
Aplicación clínica de la terapia metabólica en la cardiopatía isquémica
P Luna-Ortiz, E Rojas-Pérez, A de Micheli… - Revista Mexicana de …, 2012 - medigraphic.com
La terapia metabólica se basa en la utilización de fármacos que inhiben el metabolismo
oxidativo de los ácidos grasos y favorecen el metabolismo de la glucosa, oxidativo y no …
oxidativo de los ácidos grasos y favorecen el metabolismo de la glucosa, oxidativo y no …
Clinical application of the metabolic therapy in ischemic heart disease
P Luna-Ortiz, E Rojas-Pérez, A de Micheli… - Revista Mexicana de …, 2012 - medigraphic.com
Metabolic therapy is based on the use of drugs which inhibit the fatty acids oxidation and
promote glucose oxidation. Ischemic heart disease is cause of angina, acute myocardial …
promote glucose oxidation. Ischemic heart disease is cause of angina, acute myocardial …